Remote monitoring, Apple Heart Study and more

Remote monitoring, Apple Heart Study and more

Healio and Cardiology Today present the top stories in cardiac technology. Our readers were most interested in remote monitoring, implantable LVADs and the latest research from the Apple Heart Study.


Apple Heart Study publication offers further insights on AF detection from wearables

Results of the Apple Heart Study that were presented earlier this year at the American College of Cardiology Scientific Session have been published in The New England Journal of Medicine. Read more


Wearable devices and the revolution of cardiology via continuous care, remote monitoring

Wearable technology, including wrist-worn smartwatches and fitness monitors, is no longer the “future” of medicine. The use of wearable technologies and the potential in cardiology has become an intense topic of discussion in recent years. Of particular interest this year was the release of the Apple Heart Study data at the American College of Cardiology Scientific Session in March. Read more


Fully implantable LVAD nets FDA breakthrough device designation

Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable left ventricular assist device for patients with advanced HF. Read more


Implantable cardiac device infections affect cost, quality of life, mortality

In a new analysis from the WRAP-IT trial, patients with cardiac implantable electronic devices, or CIEDs, who had major infections from their devices had higher rates of mortality, higher costs and worse quality of life compared with those who did not. Read more


Role of wearable devices increasing in health care

The integration of wearable devices into clinical care is still in its beginning stages, but the devices’ use for ECG and the diagnosis of various arrhythmia disorders remains a top priority for research, according to a presentation at Cardiometabolic Health Congress. Read more

Source link